A peptide-doxorubicin 'prodrug' activated by prostate-specific antigen selectively kills prostate tumor cells positive for prostate-specific antigen in vivo.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples